Literature DB >> 19936966

Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan.

Ana Navarro1, Eva del Valle, Amalia Juárez, Eva Martinez, Cristina Ordóñez, Aurora Astudillo, Jorge Tolivia.   

Abstract

Apolipoprotein D (apo D) is a lipocalin present in the nervous system that may be related to processes of reinnervation, regeneration and neuronal cell protection. On the other hand, apo D expression has been correlated, in some brain regions, with normal ageing and neurodegenerative diseases. To elucidate the regional and cellular expression of apo Din normal human brain during ageing, we performed a detailed and extensive study in samples of post-mortem human cerebral cortices. To achieve this study, slot-blot techniques, for protein and mRNA,as well as immunohistochemistry and hybridohistochemistry methods, were used. A positive correlation for apo D expression with ageing was found;furthermore, mRNA levels, as well as the protein ones, were higher in the white than in the grey matter. Immunohistochemistry and non-isotopic in situ hybridization showed that apo D is synthesised in both neurons and glial cells. Apo D expression is notorious in oligodendrocytes, but with ageing, the number of neurons that synthesise apo D is increased.Our results indicate that apo D could play a fundamental role in central nervous system ageing and in the reduction of products derived from lipid peroxidation. The increment in the expression of apo D with ageing can be included in a global mechanism of cellular protection to prevent the deleterious effects caused by ageing.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19936966      PMCID: PMC2829646          DOI: 10.1007/s11357-009-9117-0

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  51 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Increased expression of apolipoprotein D following experimental traumatic brain injury.

Authors:  G Franz; M Reindl; S C Patel; R Beer; I Unterrichter; T Berger; E Schmutzhard; W Poewe; A Kampfl
Journal:  J Neurochem       Date:  1999-10       Impact factor: 5.372

3.  Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion.

Authors:  L Terrisse; D Séguin; P Bertrand; J Poirier; R Milne; E Rassart
Journal:  Brain Res Mol Brain Res       Date:  1999-06-18

4.  Identification, characterization, and tissue distribution of apolipoprotein D in the rat.

Authors:  J K Boyles; L M Notterpek; M R Wardell; S C Rall
Journal:  J Lipid Res       Date:  1990-12       Impact factor: 5.922

5.  Expression and prognostic significance of apolipoprotein D in breast cancer.

Authors:  I Díez-Itza; F Vizoso; A M Merino; L M Sánchez; J Tolivia; J Fernández; A Ruibal; C López-Otín
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

6.  Apolipoprotein D gene induction by retinoic acid is concomitant with growth arrest and cell differentiation in human breast cancer cells.

Authors:  Y S López-Boado; J Tolivia; C López-Otín
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

7.  Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D.

Authors:  S C Patel; K Asotra; Y C Patel; W J McConathy; R C Patel; S Suresh
Journal:  Neuroreport       Date:  1995-03-07       Impact factor: 1.837

8.  Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization.

Authors:  P R Provost; L Villeneuve; P K Weech; R W Milne; Y L Marcel; E Rassart
Journal:  J Lipid Res       Date:  1991-12       Impact factor: 5.922

9.  Arachidonic acid binds to apolipoprotein D: implications for the protein's function.

Authors:  J H Morais Cabral; G L Atkins; L M Sánchez; Y S López-Boado; C López-Otin; L Sawyer
Journal:  FEBS Lett       Date:  1995-06-05       Impact factor: 4.124

10.  Differential staining of nerve cells and fibres for sections of paraffin-embedded material in mammalian central nervous system.

Authors:  J Tolivia; A Navarro; D Tolivia
Journal:  Histochemistry       Date:  1994-08
View more
  7 in total

1.  Age-related changes of apolipoprotein D expression in female rat central nervous system with chronic estradiol treatment.

Authors:  Cristina Pérez; Ana Navarro; Eva Martínez; Cristina Ordóñez; Eva Del Valle; Jorge Tolivia
Journal:  Age (Dordr)       Date:  2011-07-15

Review 2.  Cooperation of Genomic and Rapid Nongenomic Actions of Estrogens in Synaptic Plasticity.

Authors:  Yu-Jie Lai; Dan Yu; John H Zhang; Guo-Jun Chen
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

3.  Lifelong expression of apolipoprotein D in the human brainstem: correlation with reduced age-related neurodegeneration.

Authors:  Ana Navarro; Elena Méndez; Celso Diaz; Eva del Valle; Eva Martínez-Pinilla; Cristina Ordóñez; Jorge Tolivia
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

4.  Cerebral Apolipoprotein-D Is Hypoglycosylated Compared to Peripheral Tissues and Is Variably Expressed in Mouse and Human Brain Regions.

Authors:  Hongyun Li; Kalani Ruberu; Tim Karl; Brett Garner
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

Review 5.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

6.  Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions.

Authors:  Ana Navarro; Beatriz Rioseras; Eva Del Valle; Eva Martínez-Pinilla; Aurora Astudillo; Jorge Tolivia
Journal:  Front Aging Neurosci       Date:  2018-08-21       Impact factor: 5.750

7.  Binding and repressive activities of apolipoprotein E3 and E4 isoforms on the human ApoD promoter.

Authors:  Louis-Charles Levros; Marilyne Labrie; Cyndia Charfi; Eric Rassart
Journal:  Mol Neurobiol       Date:  2013-05-30       Impact factor: 5.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.